Creative Medical Technology Holdings, Inc. (CELZ) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Creative Medical Technology Holdings, Inc. on June 27, 2023. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market under the symbol "CELZ".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on regulatory compliance rather than financial performance.
Material Changes
The primary event reported is the Company regaining compliance with the Nasdaq Listing Rule 5550(a)(2) regarding the minimum bid price requirement. The Company's common stock closing bid price exceeded $1.00 for 10 consecutive trading days between June 12, 2023, and June 26, 2023.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or discussion of risks and contingencies beyond the resolution of the specific listing deficiency. No unusual items were reported.
Key Facts for Investor Verification
- Confirm the Company's continued compliance with Nasdaq listing standards following this notice.
- Verify the stock price performance relative to the $1.00 threshold in the days following June 26, 2023.
- Review the attached Press Release (Exhibit 99.1) for any additional context regarding the stock price movement.